Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 1
2010 1
2011 2
2012 4
2013 4
2014 10
2015 8
2016 10
2017 9
2018 6
2019 4
2020 8
2021 7
2022 9
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and effectiveness of omalizumab in the treatment of childhood asthma.
Tortajada-Girbés M, Bousquet R, Bosque M, Carrera Martínez JJ, Ibáñez MD, Moreira A, Nieto A, Plaza AM, Rivas C, Requena G, Sánchez-Solis M, Tabar A, Torres-Borrego J, Zapatero L. Tortajada-Girbés M, et al. Among authors: requena g. Expert Rev Respir Med. 2018 Sep;12(9):745-754. doi: 10.1080/17476348.2018.1507740. Epub 2018 Aug 28. Expert Rev Respir Med. 2018. PMID: 30141696 Review.
Assortative mating in space and time: patterns and biases.
Rios Moura R, Oliveira Gonzaga M, Silva Pinto N, Vasconcellos-Neto J, Requena GS. Rios Moura R, et al. Among authors: requena gs. Ecol Lett. 2021 May;24(5):1089-1102. doi: 10.1111/ele.13690. Epub 2021 Feb 22. Ecol Lett. 2021. PMID: 33617134 Review.
Hypereosinophilic syndrome in Europe: Retrospective study of treatment patterns, clinical manifestations, and healthcare resource utilization.
Hwee J, Huynh L, Du S, Kwon N, Jakes RW, Alfonso-Cristancho R, Baylis L, Requena G, Khanal A, Rothenberg ME, Sheng Duh M. Hwee J, et al. Among authors: requena g. Ann Allergy Asthma Immunol. 2023 Jun;130(6):768-775. doi: 10.1016/j.anai.2023.02.022. Epub 2023 Mar 1. Ann Allergy Asthma Immunol. 2023. PMID: 36863663 Free article.
Peritectic titanium alloys for 3D printing.
Barriobero-Vila P, Gussone J, Stark A, Schell N, Haubrich J, Requena G. Barriobero-Vila P, et al. Among authors: requena g. Nat Commun. 2018 Aug 24;9(1):3426. doi: 10.1038/s41467-018-05819-9. Nat Commun. 2018. PMID: 30143641 Free PMC article.
Deep genomic analysis of malignant peripheral nerve sheath tumor cell lines challenges current malignant peripheral nerve sheath tumor diagnosis.
Magallón-Lorenz M, Terribas E, Ortega-Bertran S, Creus-Bachiller E, Fernández M, Requena G, Rosas I, Mazuelas H, Uriarte-Arrazola I, Negro A, Lausová T, Castellanos E, Blanco I, DeVries G, Kawashima H, Legius E, Brems H, Mautner V, Kluwe L, Ratner N, Wallace M, Fernández-Rodriguez J, Lázaro C, Fletcher JA, Reuss D, Carrió M, Gel B, Serra E. Magallón-Lorenz M, et al. Among authors: requena g. iScience. 2023 Jan 31;26(2):106096. doi: 10.1016/j.isci.2023.106096. eCollection 2023 Feb 17. iScience. 2023. PMID: 36818284 Free PMC article.
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England.
Czira A, Requena G, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS. Czira A, et al. Among authors: requena g. Int J Chron Obstruct Pulmon Dis. 2023 Apr 19;18:643-659. doi: 10.2147/COPD.S405498. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37155496 Free PMC article.
Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England.
Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo C, Yeap J, Wild R, Compton C, Rothnie KJ, Herth FJF, Quint JK, Ismaila AS. Requena G, et al. Int J Chron Obstruct Pulmon Dis. 2023 Sep 15;18:2039-2054. doi: 10.2147/COPD.S408688. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37731774 Free PMC article.
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England.
Requena G, Banks V, Czira A, Wood R, Tritton T, Wild R, Compton C, Ismaila AS. Requena G, et al. Int J Chron Obstruct Pulmon Dis. 2023 Mar 5;18:231-245. doi: 10.2147/COPD.S389281. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 36908830 Free PMC article.
83 results